MAR 09, 2016 5:30 PM PST

Can epigenetics make better cancer drugs?

Natural killer cells that can kill and contain viruses and cancerous tumors can be manipulated by epigenetics, a finding that paves the way for developing more effective cancer drugs.
 
Understanding how a new enzyme affects natural killer cells may eventually help make cancer drugs more effective, but scientists don't yet have enough information about their molecular makeup to use them in the laboratory.

“Natural killer cells are very attractive targets for immunotherapy because they are able to kill tumor cells,” says Si-Yi Chen, professor of molecular microbiology and immunology at the Keck School of Medicine at the University of Southern California.

“While scientists all around the world are working on developing new drugs using NK cells, none of the drugs in development focuses on epigenetic regulation of the cells.”

“Our study describes how an epigenetic process involving the enzyme MYSM1 plays a critical role in the development of natural killer cells.”

Epigenetics involve biochemical changes in the body that directly affect DNA, turning some genes on and turning others off. MYSM1 is an enzyme in the body’s immune system that turns genes on and off by modifying proteins called histones embedded in DNA.

For a study published in Proceedings of the National Academy of Sciences, Chen and colleagues used mice to demonstrate that MYSM1 is required for natural killer cells to mature and function properly.

“We found that MYSM1 creates access to proteins that enhance gene transcription and, ultimately, the maturation of natural killer cells themselves,” says Ph.D. student Vijayalakshmi Nandakumar, the study’s first author.

“To date, there are no elaborate reports linking an epigenetic phenomenon to natural killer cell development. More importantly, unlike conventional therapies, NK cell-based therapies have shown to be more effective against metastasis.

“We believe cancer drugs targeting this pathway could be a viable option for future immunotherapies.”

The National Institutes of Health and a Leukemia & Lymphoma Society Specialized Center of Research Award supported the research.

Source: USC

This article was originally posted on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
SEP 26, 2021
Genetics & Genomics
A Better Gene Therapy Delivery System for Treating Muscle Diseases
SEP 26, 2021
A Better Gene Therapy Delivery System for Treating Muscle Diseases
Muscle diseases that have a genetic basis can cause muscles to waste away, and may lead to a premature death. There aren ...
OCT 03, 2021
Cell & Molecular Biology
A Tumor-Suppressor Gene Plays a Role in the Circadian Rhythm
OCT 03, 2021
A Tumor-Suppressor Gene Plays a Role in the Circadian Rhythm
Organisms follow the cycle of the day, even at the cellular level, creating an internal clock. Humans' biology will ...
OCT 15, 2021
Genetics & Genomics
Genes Seem to Significantly Impact the Results We Get From Exercise
OCT 15, 2021
Genes Seem to Significantly Impact the Results We Get From Exercise
Individual health is shaped by many different factors, including the sequences and expression levels of genes, the makeu ...
OCT 29, 2021
Genetics & Genomics
An Ancestor of Modern Humans is Given a Proper Name
OCT 29, 2021
An Ancestor of Modern Humans is Given a Proper Name
Homo bodoensis is a direct ancestor of modern humans who lived in Africa during the Middle Pleistocene, and seen in this ...
NOV 14, 2021
Microbiology
Beneficial Bacteria May Help Fight Ear Infections Caused by Bacterial Pathogens
NOV 14, 2021
Beneficial Bacteria May Help Fight Ear Infections Caused by Bacterial Pathogens
Researchers have identified bacteria that have the potential to fight infections that affect the middle ear and can caus ...
NOV 18, 2021
Health & Medicine
What is TurboKnockout® Gene Targeting Technology?
NOV 18, 2021
What is TurboKnockout® Gene Targeting Technology?
Cyagen's innovative TurboKnockout(R); technology is an advanced version of ES cell-mediated gene targeting, which has sh ...
Loading Comments...